Correction: Topical application of ochratoxin A causes DNA damage and tumor initiation in mouse skin (PLoS ONE (2018) 7:10 (e47280) DOI: 10.1371/journal.pone.0047280);Topical Application of Ochratoxin A Causes DNA Damage and Tumor Initiation in Mouse Skin

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Kumar, Rahul ^a,b   Ansari, Kausar M ^a   Chaudhari, Bhushan P ^a   Dhawan, Alok ^a   Dwivedi, Premendra D ^a   Jain, Swatantra K ^b   Das, Mukul ^a  

^a CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

^b HAMDARD UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CARBONYL DERIVATIVE; CASPASE 3; CASPASE 8; CASPASE 9; CYTOCHROME C; DNA; LIPID; MITOGEN ACTIVATED PROTEIN KINASE P38; MYCOTOXIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; OCHRATOXIN; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P21; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR NRF2;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CARCINOGENESIS; CARCINOGENICITY; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CLINICAL PROTOCOL; CONTROLLED STUDY; DNA DAMAGE; ENZYME ACTIVITY; FEMALE; HISTOPATHOLOGY; LIPID PEROXIDATION; MOUSE; NONHUMAN; OXIDATIVE STRESS; POLLUTANT; PROTEIN PHOSPHORYLATION; SKIN CANCER; ULTRAVIOLET RADIATION; WESTERN BLOTTING;

EID: 84867385968     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0208284     Document Type: Erratum

References (63)

1. World Health Organization (WHO), 2011. Ultraviolet radiation and intersun programme. url: http://www.who.int/uv/faq/skincancer/en/index1.html. Accessed on August 2, 2011.
2. CAST Mycotoxins: Risks in Plant, Animal, and Human Systems. (2003) Council of Agricultural Science and Technology. Task force report No. 139, Ames, IA: CAST.
3. Kuiper-Goodman T, Scott PM, (1989) Risk assessment of the mycotoxin ochratoxin A. Biomed Environ Sci. 2: 179-248.
4. O'Brien E, Dietrich DR, (2005) Ochratoxin A: the continuing enigma. Crit Rev Toxicol 35: 33-60.
5. Vrabcheva T, Usleber E, Dietrich R, Märtlbauer E, (2000) Co-occurrence of ochratoxin A and citrinin in cereals from Bulgarian villages with a history of Balkan endemic nephropathy. J Agric Food Chem 48: 2483-2488.
6. Fink-Gremmels J (2005) Conclusions from the workshops on ochratoxin A in food: recent developments and significance, organized by ILSI Europe in Baden (Austria), 29 June-1 July 2005. Food Addit Contam (Suppl. 1): 1-5.
7. EFSA (European Food Safety Authority) Scientific Panel on Contaminants in the Food Chain (2006) Opinion of the on scientific panel on contaminants in the food chain on a request from the commission related to ochratoxin A in food. EFSA J 365: 1-56.
8. IARC (International Agency for Research on Cancer), (1993) Some naturally occurring substances: food items and constituents, heterocyclic aromatic amines and mycotoxins. In: Monographs on the evaluation of carcinogenic risk to humans. IARC Press, Lyon, vol. 56, 489.
9. Turesky RJ, (2005) Perspective: ochratoxin A is not a genotoxic carcinogen. Chem Res Toxicol 18: 1082-90.
10. WHO Food Additives Series: 47, (1998) Safety evaluation of certain mycotoxins in food. Prepared by 49th meeting of JECFA. Geneva: WHO.
11. Rastogi S, Dogra RKS, Khanna SK, Das M, (2006) Skin tumorigenic potential of aflatoxin B1 in mice. Food Chem Toxicol 44: 670-677.
12. Saxena N, Ansari KM, Kumar R, Dhawan A, Dwivedi PD, et al. (2009) Patulin causes DNA damage leading to cell cycle arrest and apoptosis though modulation of Bax, p53 and p21/WAF1 proteins in skin of mice. Toxicol App Pharmacol 234: 192-201.
13. Saxena N, Ansari KM, Kumar R, Chaudhari BP, Dwivedi PD, et al. (2011) Role of mitogen activated protein kinases in skin tumorigenicity of patulin. Toxicol App Pharmacol 257: 264-271.
14. Kumar R, Dwivedi PD, Dhawan A, Das M, Ansari KM, (2011) Citrinin-generated reactive oxygen species cause cell cycle arrest leading to apoptosis via the intrinsic mitochondrial pathway in mouse skin. Toxicol Sci 122: 557-566.
15. Singh NP, Mecony MT, Tice RR, Schneider EL, (1998) A simple technique of quantitation of low levels of DNA damage in individual cells. Exp Cell Res 175: 184-191.
16. Hobbs CA, Paul BA, Gilmour SK, (2003) Elevated levels of polyamines alter chromatin in murine skin and tumors without global changes in nucleosome acetylation. Exp Cell Res 290: 427-436.
17. Ellman GL, (1959) Tissue sulphydryl groups. Arch Biochem Biophys 82: 70-77.
18. Utley GH, Bernheim F, Hochstein P, (1967) Effect of sulphydryl reagents on peroxidation in microsomes. Arch Biochem Biophys 118: 29-32.
19. Levine RL, Garland D, Oliver CN, Amici A, Climent I, et al. (1990) Determination of carbonyl content of oxidatively modified proteins. Methods Enzymol 186: 464-478.
20. Sinha AK, (1972) Colorimetric assay of catalase. Anal Biochem 47: 389-394.
21. Moron MS, Depierre JW, Mannervik B, (1979) Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim Biophys Acta 582: 67-78.
22. Pfohl-Leszkowicz A, Manderville RA, (2007) Ochratoxin A: An overview on toxicity and carcinogenicity in animals and humans. Mol Nutr Food Res 51: 61-99.
23. Abel EL, Angel JM, Kiguchi K, Digiovanni J, (2009) Multi-stage chemical carcinogenesis in mouse skin: Fundamentals and applications. Nat Protoc 4: 1350-1362.
24. Poirier MC, (2004) Chemical-induced DNA damage and human cancer risk. Nat Rev Cancer 4: 630-637.
25. Mally A, Pepe G, Ravoori S, Fiore M, Gupta RC, et al. (2005) Ochratoxin A causes DNA damage and cytogenetic effects but no DNA adducts in rats. Chem Res Toxicol 18: 1253-1261.
26. Kamp HG, Eisenbrand G, Schlatter J, Würth K, Janzowski C, (2005) Ochratoxin A: induction of (oxidative) DNA damage, cytotoxicity and apoptosis in mammalian cell lines and primary cells. Toxicology 206: 413-425.
27. Marin-Kuan M, Ehrlich V, Delatour T, Cavin C, Schilter B (2011) Evidence for a role of oxidative stress in the carcinogenicity of Ochratoxin A. J Toxicol Article ID 645361, 15 pages, doi: 10.1155/2011/645361.
28. Rogaku EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM, (1998) DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 273: 5858-5868.
29. Paull TT, Rogakou EP, Yamazaki V, Kirchgessner CU, Gellert M, et al. (2000) A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr Biol 10: 886-895.
30. Kensler TW, Wakabayashi N, Biswal S, (2007) Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Ann Rev Pharmacol Toxicol 47: 89-116.
31. Cavin C, Delatour T, Marin-Kuan M, Holzhäuser D, Higgins L, et al. (2007) Reduction in antioxidant defenses may contribute to ochratoxin A toxicity and carcinogenicity. Toxicol Sci 96: 30-39.
32. Burdon RH, (1995) Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Radic Biol Med 18: 775-794.
33. Kamata H, Hirata H, (1999) Redox regulation of cellular signaling. Cell Signal 11: 1-14.
34. Benhar M, Engelberg D, Levitzki A, (2002) ROS, stress-activated kinases and stress signaling in cancer. EMBO Rep 3: 420-425.
35. Johnson GL, Lapadat R, (2002) Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298: 1911-1912.
36. Dhillon AS, Hagan S, Rath O, Kolch W, (2007) MAP kinase signaling pathways in cancer. Oncogene 26: 3279-3290.
37. Wada T, Penninger JM, (2004) Mitogen-activated protein kinases in apoptosis regulation. Oncogene 23: 2838-2849.
38. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME, (1995) Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270: 1326-1331.
39. Rumora L, Grubišić TŽ, (2009) A journey through mitogen-activated protein kinase and Ochratoxin A interactions. Arh Hig Rada Toksikol 60: 449-456.
40. Gutteridge JM, Halliwell B, (2010) Antioxidants: Molecules, medicines, and myths. Biochem Biophys Res Commun 393: 561-564.
41. Jiang L, Sheikh MS, Huang Y, (2010) Decision making by p53: Life versus Death. Mol Cell Pharmacol 2: 69-77.
42. Atroshi F, Biese I, Saloniemi H, Ali-Vehmas T, Saari S, et al. (2000) Significance of apoptosis and its relationship to antioxidants after ochratoxin A administration in mice. J Pharm Pharmaceut Sci 3: 281-291.
43. Petrik J, Žanić-Grubišić T, Barišić K, Pepeljnjak S, Radić B, et al. (2003) Apoptosis and oxidative stress induced by ochratoxin A in rat kidney. Arch Toxicol 77: 685-693.
44. Mantle PG, Milijkovic A, Udupa V, Dobrota M, (1998) Does apoptosis cause renal atrophy in Balkan endemic nephropathy? Lancet 352: 1118-1119.
45. Abbas T, Dutta A, (2009) p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer 9: 400-414.
46. Farnebo M, Bykov VJN, Wiman KG, (2010) The p53 tumor suppressor: A master regulator of diverse cellular processes and therapeutic target in cancer. Biochem Biophys Res Commun 396: 85-89.
47. Jurgensmeier JM, Xie Z, Deveraux Q, Ellerby L, Bredesen D, et al. (1998) Bax directly induces release of cytochome c from isolated mitochondria. Proc Natl Acad Sci USA 95: 4997-5002.
48. Cecconi F, (1999) Apaf1 and the apoptotic machinery. Cell Death Differen 6: 1087-1098.
49. Kaufmann SH, Desnoyers S, Ottaviano Y, Davidson NE, Poirier GG, (1993) Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res 53: 3976-3985.
50. Assaf H, Azouri H, Pallardy M, (2004) Ochratoxin A Induces Apoptosis in Human Lymphocytes through Down Regulation of Bcl-xL. Toxicol Sci 79: 335-344.
51. Chopra M, Link P, Michels C, Schrenk D, (2010) Characterization of ochratoxin A-induced apoptosis in primary rat hepatocytes. Cell Biol Toxicol 26: 239-254.
52. Slaga TJ, Fischer SM, Nelson K, Gleason GL, (1980) Studies on the mechanism of skin tumor promotion: Evidence for several stages in promotion. Proc Natl Acad Sci USA 77: 3659-3663.
53. Flora SD, Scarfì S, Izzotti A, D'agostini F, Chang C, et al. (2006) Induction by 7,12-dimethylbenz(a)anthracene of molecular and biochemical alterations in transformed human mammary epithelial stem cells, and protection by N-acetylcysteine. Int J Oncol 29: 521-529.
54. Frenkel K, Wei L, Wei H, (1995) 7,12-dimethylbenz[a]anthracene induces oxidative DNA modification in vivo. Free Radic Biol Med 19: 373-380.
55. Vesela D, Vesely D, Jelinek R, Kusak V, (1978) Detection of Ochratoxin A in feed barley. Vet Med 23: 431-436.
56. Czerwiecki L, Czajkowska D, Witkowska-Gwiazdowska A, (2002) On ochratoxin A and fungal flora in Polish cereals from conventional and ecological farms. Part 2: Occurrence of ochratoxin A and fungi in cereals in 1998. Food Addit Contam 19: 1051-1057.
57. Rizzo A, Eskola M, Atroshi F, (2002) Ochratoxin A in cereals, foodstuffs and human plasma. Eur J Plant Pathol 108: 631-637.
58. Pohland AE, Nesheim S, Friedman L, (1992) Ochratoxin A: A review. Pure Appl Chem 64: 1029-1046.
59. Kim SJ, Ko CB, Park C, Kim BR, Sung TH, et al. (2005) p38 MAP kinase regulates benzo(a)pyrene-induced apoptosis through the regulation of p53 activation. Arch Biochem Biophys 444: 121-129.
60. Rämet M, Castrén K, Järvinen K, Pekkala K, Turpeenniemi-Hujanenhttp://carcin.oxfordjournals.org/content/16/9/2117.abstract?sid = c9deb512-e8b4-4854-aa3e-b9cba63e9a5f- aff-2 T, et al (1995) p53Protein expression is correlated with benzo[a]pyrene-DNA adducts in carcinoma cell lines. Carcinogenesis 16: 2117-2124.
61. Zhao Y, Oberley TD, Chaiswing L, Lin S, Epstein CJ, et al. (2002) Manganese superoxide dismutase deficiency enhances cell turnover via tumor promoter-induced alterations in AP-1 and p53-mediated pathways in a skin cancer model. Oncogene 21: 3836-3846.
62. Allen SM, Florell SR, Hanks AN, Alexander A, Diedrich MJ, et al. (2003) Survivin expression in mouse skin prevents papilloma regression and promotes chemical-induced tumor progression. Cancer Res 63: 567-572.
63. Iskander K, Gaikwad A, Paquet M, Long II DJ, Brayton C, et al. (2005) Lower induction of p53 and decreased apoptosis in NQO1-null mice lead to increased sensitivity to chemical-induced skin carcinogenesis. Cancer Res 65: 2054-2058.